The VEITH 2022 symposium witnessed a series of clinical data supporting the use of the sirolimus-coated balloon in the treatment of below-knee disease. Concept Medical Inc. hosted a luncheon symposium entitled "Sirolimus-Coated Balloon in the Treatment of PAD: Choice of the Future", which explored the utility of the sirolimus-coated balloon in the treatment of PAD. The session was chaired by Prof. Sahil Parikh , co-moderated by Prof. Edward Choke and Prof. Aloke Finn with interesting presentations by Prof. Ulf Teichgräber and Prof. Francesco Liistro .One of the highlights of the session was the follow-up of the clinical results of the XTOSI trial. XTOSI ( X treme Touch Si rolimus coated PTA balloon) is a single-arm trial for the sirolimus coated balloon ( MagicTouch PTA ) investigating the clinical use and safety of the device in the treatment of peripheral arterial disease (PAD) in the infrainguinal area. This prospective, pre-marketing, non-randomized, single-arm, all-participant study led by Principal Investigator Prof. Edward Choke enrolled 50 patients to study the Magic Touch PTA sirolimus-coated balloon  ( Concept Medical Inc. .) at Sengkang General Hospital, Singapore. It is the first global trial of the sirolimus-coated balloon for BTK disease and has the longest follow-up data. While the primary endpoints already suggested promising patency and safety at 6 months, the data presented at VEITH 2022 provided further clarity on the long-term efficacy and safety of the sirolimus-coated balloon.

Prof. Edward Choke also presented updates on the FUTURE SFA and FUTURE BTK RCTs, a family of randomized trials designed to enroll 279 and 219 patients, respectively, compared to the standard uncoated balloon in a 2:1 ratio and are in progress. course in Singapore, Taiwan and Thailand. FUTURE BTK has already completed 25% of its enrollment goal, thanks to the merit of the principal investigators of all the centers involved.

The sirolimus-coated balloon for the treatment of PAD continues its march, knocking on the doors of the United States and lighting up New York 's iconic Times Square with a dazzling presentation of the results of the XTOSI study and the enrollment status of the FUTURE study BTK.

Watch the full session for more interesting clinical facts: https://youtu.be/2xokmMuhzuc

Logo: https://mma.prnewswire.com/media/1926812/Concept_Medical_Logo.jpg
Photo: https://mma.prnewswire.com/media/1960489/Edward_Choke_MagicTouch_XTOSI.jpg

FUENTE Concept Medical Inc.

 

Source:prnewswire.com

Report Abuse